Glucosamine Supplement Potentially Linked to Faster Alzheimer's Progression

Preliminary research from the University of Florida suggests a popular joint supplement, glucosamine, may be associated with a 25% higher likelihood of mild cognitive impairment advancing to dementia. Laboratory experiments indicate glucosamine could intensify an abnormal sugar-tagging process in the Alzheimer's brain. Published in Nature Metabolism, these findings are preliminary and require confirmation through controlled human clinical trials, raising questions about its use in individuals with cognitive impairment.